This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...

Trinity College Dublin researchers, based at St James’s Hospital have provided important insights into the behaviour and metabolic function of a previously largely unknown, but crucial ‘natural killer ...

which are isolated from a variety of natural sources such as humans, animals, and microorganisms, and personalised therapies are some science advances that may potentially treat COPD in the future.

Arguably the most buzzed about advancement in the COPD treatment landscape is the emergence of new ... “When you take that diseased part out, that helps to restore the lung’s natural mechanics,” Han ...

Our COPD Clinic provides the latest treatment options for patients with advanced COPD. BIDMC is the first hospital in Boston and the second in the United States to offer minimally invasive ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

Advancements in Diagnostic Technologies and Treatments: Development of technological advancement is one of the key factors enhancing the growth of the COPD diagnosis and treatment industry.

Research provides a foundation for further exploration of NK cells for the development of future treatments and therapies for ...